Hepatocellular Carcinoma
📧 Sign up to get email alerts when something new happens for Hepatocellular Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Adjuvant Sintilimab Plus Lenvatinib for HCC Characterized With VETC Following Liver Resection [NA]
This trial update describes evaluating adjuvant therapy with sintilimab plus lenvatinib for hepatocellular carcinoma with VETC after liver r…
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: The Efficacy and Safety of First-line Treatment Combined With Immunotherapy for Advanced Hepatocellular Carcinoma: a Single Center, Real-world Study
This real-world, single-center study assesses first-line treatment combined with immunotherapy for advanced hepatocellular carcinoma and is …
-
CLINICAL_TRIALS trial_result · 2025-07-22Clinical Trial Update: Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma [Phase 1]
Phase 1 clinical trial evaluating an mRNA vaccine in liver transplantation for hepatocellular carcinoma is currently recruiting.
-
CLINICAL_TRIALS research · 2025-07-22Clinical Trial Update: Predicting Immunotherapy Response and Survival of Liver Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Liver)
A clinical trial investigating artificial intelligence and radiomics to predict immunotherapy response and survival in patients with hepatoc…
-
CLINICAL_TRIALS research · 2025-07-20Clinical Trial Update: JDB153 Combined With Penpulimab for Hepatocellular Carcinoma After Standard Treatment Failure [Phase 1, Phase 2]
This document outlines a Phase 1/Phase 2 clinical trial evaluating JDB153 combined with Penpulimab for refractory hepatocellular carcinoma a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: TACE Plus Bevacizumab for Hepatocellular Carcinoma With Portal Vein Invasion [NA]
A completed clinical trial investigated transarterial chemoembolization (TACE) plus bevacizumab for hepatocellular carcinoma with portal vei…
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Digital Early Warning System for Acute Lung Injury in Liver Surgery
A ClinicalTrials.gov entry describing a study of a digital early warning system to detect acute lung injury in patients undergoing liver sur…
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy. [NA]
Clinical trial update NCT06248528 in hepatocellular carcinoma with portal vein tumor thrombosis compares surgical resection to locoregional …
-
CLINICAL_TRIALS research · 2025-07-16Clinical Trial Update: Hepatocellular Carcinoma Imaging Using PSMA PET/CT [Phase 2]
Phase 2 clinical trial evaluating PSMA PET/CT imaging for hepatocellular carcinoma; the study is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: Pembrolizumab (MK-3475) in Hepatocellular Carcinoma [Phase 2]
Phase 2 study of pembrolizumab (MK-3475) in hepatocellular carcinoma (BCLC stages B and C) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2025-07-15Clinical Trial Update: RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System [NA]
This completed randomized controlled trial evaluated screening strategies for hepatocellular carcinoma among high-risk patients in a safety-…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: A Generative Model-based System for Predicting Survival and Guiding Treatment Decisions in Patients With Unresectable Hepatocellularcarcinoma Undergoing Transcatheter Arterial Chemoembolization in Combination With Immunotherapy and Targeted Therapy
A clinical trial update describes a generative model-based system to predict survival and guide treatment decisions for patients with unrese…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Tauroursodeoxycholic Acid Combined With PD-1/PD-L1 Immunotherapy in Advanced Hepatocellular Carcinoma: A Prospective Study [Phase 2]
A Phase 2 prospective trial evaluating tauroursodeoxycholic acid in combination with PD-1/PD-L1 immunotherapy for advanced hepatocellular ca…
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: Targeted Navigation in Hepatocellular Carcinoma (HCC) [NA]
A University of Miami-sponsored clinical trial is currently recruiting to study targeted navigation approaches in hepatocellular carcinoma, …
-
CLINICAL_TRIALS research · 2025-07-15Clinical Trial Update: The Real-world Study of AK104 Combining With TACE for Resectable Hepatocellular Carcinoma (MORNING)
A real-world study assessing AK104 in combination with transarterial chemoembolization (TACE) for patients with resectable hepatocellular ca…
-
CLINICAL_TRIALS trial_result · 2025-07-14Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial reports on the safety, tolerability, pharmacokinetics, and pharmacodynamics of INCB099280 in participants with advanced s…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors [Phase 2]
Telix's phase 2 trial of the CAIX-targeting PET tracer 89Zr-girentuximab in CAIX-positive solid tumors was terminated.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Liver Cancer and Immunotherapy in the Liquid Biopsy Era [NA]
An update on an ongoing clinical trial at University Hospital, Montpellier, evaluating immunotherapy and liquid biopsy approaches for hepato…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: Downstaging Prediction Model for HCC
An update on a clinical trial to develop a downstaging prediction model for hepatocellular carcinoma; the study is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Hepatocellular Carcinoma 3 Gene Methylation Combination Detection Kit (PCR Fluorescent Probe Method) Multicenter Clinical Trial
Ongoing multicenter clinical trial evaluating a 3-gene methylation-based detection kit for hepatocellular carcinoma using a PCR fluorescent …
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: Intra-procedural 360-degree Display for Performing Percutaneous Liver Tumor Ablation
A completed clinical trial evaluated a 360-degree intra-procedural display to assist percutaneous liver tumor ablation, assessing its potent…
-
CLINICAL_TRIALS trial_result · 2025-07-08Clinical Trial Update: TACE With Immune Agents for Angiogenesis in Hepatocellular Carcinoma [NA]
A completed clinical trial evaluating transarterial chemoembolization with immune agents to target angiogenesis in hepatocellular carcinoma.
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: The Diagnostic Efficacy and Lesion Detection Advantages of 18F-FDG PET/Contrast-enhanced MRI in Malignant Liver Lesions
This clinical trial will evaluate the diagnostic accuracy of 18F-FDG PET with contrast-enhanced MRI for detecting malignant liver lesions.
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: The Efficacy of Sequential RT After Triple Therapy for uHCC
This entry reports a clinical trial evaluating sequential radiotherapy after triple therapy for unresectable hepatocellular carcinoma; the s…
-
CLINICAL_TRIALS research · 2025-07-04Clinical Trial Update: A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial of Tegavivint (BC2059) in patients with advanced hepatocellular carcinoma is currently recruiting.